Third Wave files patent suits against Digene, Chiron and Bayer ( egal action: -- Third Wave sued by on...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Third Wave files patent suits against Digene, Chiron and Bayer

egal action:
-- Third Wave sued by one firm; gets injunction against another
-- Stratagene to appeal verdict won by Third Wave......

Full article >>>

Source:wistechnology.com By WTN News 10/12/05

Page: 1 2
Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Third Wave reports net loss of $18.9M for 2006
3. Stratagene to pay Third Wave $10.75M in patent case
4. Third Wave responds to Digene patent lawsuit
5. Third Wave seeks approval of Cystic Fibrosis test
6. Third Wave Technologies to raise $14.9M through private debt
7. Third Wave reports $5.2M third quarter loss
8. Third Wave reports another loss, stronger sales
9. Napier joins board of Third Wave Technologies
10. Third Waves revenues rebound
11. Third Wave reports clinical growth, continued loss

Post Your Comments:

Breaking Biology Technology:New technology could boost disease detection tests' speed and sensitivity 2 Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2 Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project 2 Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 2 Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project 3

[0] New technology could boost disease detection tests' speed and sensitivity [0] Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery [0] Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project [1] Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project

Other Biology Technology:Evidence of macroscopic quantum tunneling detected in nanowires 2 Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine 2 Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine 3 SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY 2 SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY 3

Evidence of macroscopic quantum tunneling detected in nanowires Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY

Breaking Biology News(10 mins):New understanding of how to prevent destruction of a tumor suppressor 2 Improving the odds 2 A virtual physician's conference 2 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 1 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 2 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 3 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 4 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 5 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 6 Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis 28PMO 29 13216 7 Zimmer Launches New Medical Education and BioSkills Training Program 13214 1 Zimmer Launches New Medical Education and BioSkills Training Program 13214 2 Zimmer Launches New Medical Education and BioSkills Training Program 13214 3 Zimmer Launches New Medical Education and BioSkills Training Program 13214 4 Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 1 Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special Boulder Flair to Chamber Members 52834 2

[0] New understanding of how to prevent destruction of a tumor suppressor [0] Improving the odds [0] A virtual physician's conference

Other Biology News:NIH launches Human Microbiome Project 2 NIH launches Human Microbiome Project 3 NIH launches Human Microbiome Project 4 NIH launches Human Microbiome Project 5 Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows 2 bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line 2 bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line 3

NIH launches Human Microbiome Project Widespread support for nonembryonic stem cell research, VCU Life Sciences Survey shows bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line

Biology Products:

T4 DNA Ligase; (1 x 10³ U/ml) or (5 x 10³ U/ml) supplied with 10x ligation buffer that includes ATP from Roche Applied Science Mouse Anti-Mouse MHC Class I H-2Kd, Dd, q, u, v Monoclonal Antibody, Biotin Conjugated, Clone A5A1-Do4 from Meridian Life Science, Inc.Rabbit Anti-Neuromedin U Receptor 1 Polyclonal Antibody, Unconjugated from Novus Biologicals Hybridoma Storage from AbD Serotec